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Abstract
The binding of sequence-specific regulatory factors and the recruitment of chromatin remodeling
activities cause nucleosomes to be evicted from chromatin in eukaryotic cells. Traditionally, these
active sites have been identified experimentally through their sensitivity to nucleases. Here we
describe the details of a simple procedure for the genome-wide isolation of nucleosome-depleted
DNA from human chromatin, termed FAIRE (Formaldehyde Assisted Isolation of Regulatory
Elements). We also provide protocols for different methods of detecting FAIRE-enriched DNA,
including use of PCR, DNA microarrays, and next-generation sequencing. FAIRE works on all
eukaryotic chromatin tested to date. To perform FAIRE, chromatin is crosslinked with formaldehyde,
sheared by sonication, and phenol-chloroform extracted. Most genomic DNA is crosslinked to
nucleosomes and is sequestered to the interphase, whereas DNA recovered in the aqueous phase
corresponds to nucleosome-depleted regions of the genome. The isolated regions are largely
coincident with the location of DNaseI hypersensitive sites, transcriptional start sites, enhancers,
insulators, and active promoters. Given its speed and simplicity, FAIRE has utility in establishing
chromatin profiles of diverse cell types in health and disease, isolating DNA regulatory elements en
masse for further characterization, and as a screening assay for the effects of small molecules on
chromatin organization.
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Introduction
In eukaryotes, packaging of DNA into chromatin reduces the accessibility of genetic
information to the set of proteins involved in regulating DNA-templated processes such as
transcription. Successful orchestration of DNA-dependent processes is achieved in part by
regulating the stability of nucleosomes at these sites [1–3]. Here “stability” refers to the
probability of an intact nucleosome at a given nucleotide position, versus a nucleosome in an
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absent or disrupted state at that position. Several mechanisms exist to modulate nucleosome
stability, including competition with sequence-specific factors [4–7], ATP-dependent
nucleosome remodeling complexes [8–10] and post-translational modifications of the histone
tails [11–14]. Nucleosome stability at any given locus is governed by a combination of factors
acting in concert, which results in a context-specific set of DNA elements bound by regulatory
factors for each cell type.
Traditionally, active regulatory elements have been identified by their increased sensitivity to
nuclease digestion, such as DNase I [15–20]. Typically this involves subjecting isolated nuclei
to a mild nuclease treatment, followed by detection using Southern blots to identify nuclease
hypersensitive sites. Several groups have recently adapted the procedure for genome-wide
detection with DNA microarrays or next-generation sequencing [21–24]. However,
requirements for a clean nuclei preparation from a single-cell suspension, and the need for
laborious enzyme titrations means that it is difficult to perform DNase hypersensitivity assays
on solid tissues, on a limited number of cells, or in parallel on many different samples.
Here we describe an alternative strategy for genome-wide isolation of active regulatory
elements termed FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). It is a
simple, high-throughput procedure to isolate and map genomic regions depleted of
nucleosomes. The procedure involves crosslinking proteins to DNA using formaldehyde,
shearing the chromatin, and performing a phenol-chloroform extraction. The genomic regions
preferentially segregated into the aqueous phase are then mapped back to the genome by
hybridization to tiling microarrays or are read directly using next-generation DNA sequencing
(Figure 1). Quantitative PCR can be used to assay individual loci, which is useful when
screening many cell or tissue types. The relatively straightforward nature and tractability of
FAIRE has broad utility for the genome-wide detection of active regulatory elements across
all eukaryotic species, in clinical samples, and for high-throughout screens.
FAIRE was first demonstrated in Saccharomyces cerevisiae [25]. In yeast, the genomic regions
immediately upstream of genes were preferentially segregated into the aqueous phase, in a
manner that was strongly negatively correlated with nucleosome occupancy [26–29].
Subsequent studies demonstrated that FAIRE efficiently isolated nucleosome-depleted regions
of the Homo sapiens genome, which included both transcription start sites and distal regulatory
elements such as enhancers and silencers [30] (Figure 2). Results from both yeast and human
found that enrichment of the upstream regions of genes was positively correlated with
transcription of the downstream gene. However, in human cells the vast majority of sites
identified were far from any annotated gene. For the majority of these distal sites, it is not yet
possible to ascribe a function, identify what factors might be bound, or determine the genes
being regulated by each regulatory element.
The enrichment of regulatory regions in the aqueous phase is thought to result from the very
high crosslinking efficiency of histone proteins to DNA, versus the lower efficiency of
crosslinking sequence-specific proteins to DNA. This difference in crosslinking efficiency is
likely due in part to formaldehyde’s very short crosslinking distance. Formaldehyde is a small
molecule (HCHO) and crosslinks are only formed between proteins and DNA in direct contact.
There are approximately 10 to 15 histone-DNA interactions within a nucleosome that serve as
potential crosslinking sites [31]. However, for most DNA-binding proteins there are far fewer
potential crosslinking sites. The average binding sites are 5 to 15 bp [32], with only a few of
the bases close enough to the protein contacts be crosslinked [33]. In addition, formaldehyde
requires a ε-amino group such as occurs on lysine, to form a crosslink [34,35]. Approximately
10% of the amino-acid composition of histones are lysine, a much higher proportion than a
typical protein. Due to both of these factors nucleosomes are much more readily crosslinkable
to DNA, and are likely to dominate the crosslinking profile (Figure 3).
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The following provides a general framework for performing FAIRE, which specifically
emphasizes performing FAIRE on cells grown in culture. The final methods section provides
the modifications required to perform FAIRE on tissue samples. The protocols for cells and
tissues are also included as one-page supplementary files for easier use at the bench.
Crosslinking—For cells grown in culture, add 37% formaldehyde directly to the growth
media to a final concentration of 1% and incubate at room temperature on an orbital shaker at
80 rpm. Typically, we incubate for 30 minutes for yeast and 5 minutes for human cultured
cells, although these times will vary for different species and cell types. Generally, whatever
fixation time and conditions are used for ChIP (Chromatin Immunoprecipitation) experiments
will be adequate for FAIRE, with slightly shorter fixation times often being optimal. To quench
the fixation, add 2.5 M glycine to a final concentration of 125 mM and incubate for 5 min at
room temperature while continuing to shake. Cells grown in suspension should be collected
by centrifugation at 700 × g for 5 min at 4 °C. For adherent cells, first remove the media
containing formaldehyde and glycine, add ice-cold PBS to cover the cell layer, scrape, and
transfer the cells to a conical tube. For both adherent cells and cells in suspension, wash two
more times with ice-cold PBS to ensure all residual media is removed.
Cell lysis—Resuspend cells in 1 ml of lysis buffer (2% Triton X-100, 1% SDS, 100 mM
NaCl, 10 mM Tris-Cl pH 8.0, 1 mM EDTA) per 107 (or 0.4g of) cells. Transfer 1 ml of lysis
solution to 2 ml screw-capped tube with rubber seal and add 1 ml of 500 μM glass beads. Cell
disruption is performed in a mini bead-beater (Mini-BeadBeater-8, BioSpec Inc.) set to
homogenize for five 1-minute sessions with 2-minute incubations on ice between sessions (see
the alternative protocol if a Beadbeater is not available). To recover the lysate, puncture the
bottom of the 2 ml tube with a 25G syringe and drain into 15 ml tube on ice. Once the lysate
has drained, add an additional 500 μl lysis buffer to clear any remaining sample from the beads.
Filtered air can be used to push the liquid through the hole in the bottom of the tube. Proceed
directly to sonication.
Cell lysis: alternative protocol—If a bead-beater is not available, the following procedure
is suitable for human or similar cell types, but not yeast [36]. This procedure often requires
additional rounds of sonication. Add 10 ml of Lysis Buffer 1 (50 mM HEPES-KOH, pH 7.5,
140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25% Triton X-100) per 108 cells
and rock at 4° C for 10 minutes. Spin at 1,300 × g for 5 minutes at 4° C and remove supernatant.
Add 10 ml of Lysis Buffer 2 (10 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM
EGTA) per 108 cells and rock at room temperature for 10 minutes. Spin at 1,300 × g for 5
minutes at 4° C and remove supernatant, at this point the pellet should appear white and fluffy.
Add 3.5 ml of Lysis Buffer 3 (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM
EGTA, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine) per 108 cells. Proceed directly to
sonication.
Sonication—Transfer the lysate to 1.5 ml tubes in 300 μl aliquots and sonicate for 15 minutes
using a Bioruptor UCD-200 (Diagenode) set to pulse on high for 30 seconds followed by 30
seconds of rest. The water bath should be maintained at a constant temperature of 4° C using
a recirculator. Alternatively one may use a microtip sonicator (Branson Sonifier 450) set at
15% amplitude for five sessions of sixty pulses (1 second on/1 second off), incubating the
sample on ice for two minutes between sessions. Clear the lysate of cellular debris by spinning
at 15,000 × g for 5 minutes at 4° C, transfer supernatant to a new tube. Run an aliquot, equivalent
Giresi and Lieb Page 3













to 500 ng total genomic DNA, on a 1% agarose gel to ensure fragment sizes range between
100–1000 bp.
Phenol/Chloroform extraction—Add a volume of phenol/chloroform (Sigma #P3803
phenol, chloroform, and isoamyl alcohol 25:24:1 saturated with 10mM Tris, pH 8.0, 1 mM
EDTA) that is equal to the volume of the lysate, vortex well, spin at 12,000 × g for 5 minutes,
and transfer the aqueous fraction to a fresh 1.5 ml tube. If there is very little aqueous phase due
to an exceptionally large interphase, remove aqueous phase, add 500 μl TE to old interphase,
vortex, and spin again. To ensure all protein has been removed, perform an additional extraction
by adding an equal volume of phenol/chloroform to the isolated aqueous fraction. Finally, add
an equal volume of chloroform (Fluka BioChemika 25666, chloroform, isoamyl alcohol 24:1)
to the aqueous fraction, spin, and transfer aqueous phase to a new tube.
DNA precipitation—Add 3M sodium acetate (pH 5.2) to a final concentration of 0.3 M, and
add 1 μl of 20 mg/ml glycogen. Mix by inverting. Add two volumes of 95% ethanol mix by
inverting and incubate at −20° C overnight. Although overnight incubations are routinely
performed, incubation as short as one hour should be sufficient. Pellet the precipitate by
spinning at 15,000 × g for 30 minutes at 4° C, wash the pellet with 500 μl ice cold 70% ethanol,
spin at 15,000 × g for 5 minutes at room temperature, remove the supernatant, and dry pellet
in a speed-vac. Resuspend the dried pellet in 50 μl of 10 mM Tris-HCl pH 7.5. Add 1 μl of 10
mg/ml RNase A and incubate for 1 hour at 37° C. Earlier versions of the protocol included a
step that incubates DNA from crosslinked samples at 65° C overnight to ensure that any DNA-
DNA crosslinks do not interfere with downstream enzymatic steps. However, we have found
that skipping this step results in no detectable difference in the efficiency of downstream
enzymatic reactions.
Clean up the sample using either a spin column capable of recovering small DNA fragments
(75–200 bp) or perform an additional phenol/chloroform extraction and ethanol precipitation.
We have found that this is necessary to achieve accurate spectrophotometric measurements of
our samples for subsequent reactions. Depending on the number of cells used for FAIRE and
the final concentration, it may be possible to see the size distribution of FAIRE DNA fragments
on a 1% agarose gel, which typically ranges between 75–200 bp. However, gel verification is
not necessary and is often omitted.
Tissue samples—The following modifications for performing FAIRE in tissues include
steps to prepare the tissue sample for crosslinking, disassociating the cells, and cell lysis. These
modifications have been successfully used on tissue samples as small as 10 mg. Other
considerations for working with tissue samples include whether it is fresh or frozen, and how
fibrous the tissue is. For fresh soft tissues, such as brain, simply mince the tissue into small
pieces using a scalpel, transfer to a dounce with 1 ml of PBS containing 37% formaldehyde at
a final concentration of 1%, and incubate for 5 minutes at room temperature (22–25°C) with
swirling. Add 2.5 M glycine to a final concentration of 125 mM glycine and incubate for an
additional 5 minutes. Disassociate the cells with a dounce homogenizer, wash two times with
ice cold PBS, and proceed with cell lysis and all remaining steps for FAIRE as described above.
For previously frozen tissues or fresh fibrous tissues, samples should be placed in a 15 ml
conical tissue grinder (VWR #47732-446), precooled in a liquid nitrogen bath, incubated for
10 minutes, and ground into a powder until roughly the consistency of sand. Remove the 15
ml tube containing the powder from liquid nitrogen bath, add 1.5 ml of room-temperature PBS
containing 1% formaldehyde per 10 mg of tissue, and incubate for 7 minutes at room
temperature. For most tissue types you can proceed with the protocol described above, but for
especially tough tissue types use larger 2.8 mm ceramic or metal beads (Precellys CK28 or
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MK28) and perform additional cycles in the mini bead-beater for an efficient lysis before
sonication.
Detection and analysis of FAIRE DNA
Quantitative PCR—Quantitative PCR (qPCR) is used both as a method for detecting open
chromatin sites and as a means to validate sites identified using either DNA microarray or high-
throughput sequencing data. There are several considerations when designing qPCR
experiments, including selection of an appropriate set of reference regions, exact primer
localization, and methods for quantitation of the results. It is important to select an appropriate
set of reference regions since these will be used to calculate relative enrichment for all other
sites tested. This can be difficult due to the limited knowledge of “gold standard” sites of closed
chromatin available for most species. Even for cells in which sites of closed chromatin have
been mapped, these may be limited to a specific growth condition. Therefore we often use a
tiling approach (Figure 1B) for detection of open chromatin sites using qPCR. Here, primer
pairs are designed such that the products are either overlapping or closely spaced across the
genomic regions being interrogated. The reference regions are those primer sets flanking the
regions isolated by FAIRE. This strategy is also useful for validating results from microarray
and sequencing data, which requires a set of positive and negative sites to determine both
sensitivity and specificity. Primer design is also critical for obtaining accurate results from
qPCR, since primer pairs spanning or near the edges of open chromatin sites may be able to
only detect a subset of the DNA fragments isolated in the aqueous phase (Figure 1B).
Optimally, primer pairs should be designed to amplify 60–100 bp products within the central
portion of the identified regions. We typically calculate the relative enrichment for each
amplicon using the comparative cT method [37]. Here, a ratio is calculated using the signal
from the FAIRE sample relative to the signal from DNA prepared from an uncrosslinked
sample. All ratios are then normalized to the amplicon with the lowest ratio, which is typically
from the reference regions. Relative quantitation is used in part because FAIRE enriches for
mitochondrial DNA, and since the mitochondrial content can vary considerably between cells
it is difficult to get an accurate measurement of the proportion of genomic DNA enriched in
each of the FAIRE samples.
Detection by DNA microarray—High quality FAIRE data has been obtained from several
microarray platforms, including Agilent, NimbleGen (Roche), and PCR-based arrays. Any
microarray platform will suffice, but there are several factors to consider, such as the type of
probe, the genomic regions covered, and the resolution [38]. One of the most important for
FAIRE is selecting a microarray design with sufficient resolution (Figure 1C). For
oligonucleotide (50–75 bp) tiling microarrays, probe-to-probe spacing should not exceed 100
bp if possible. Doing so reduces the number of probes per FAIRE site to just one or two.
Typically, we amplify the DNA using ligation-mediated (LM) PCR [39]. The DNA fragments
are made blunt using T4 DNA polymerase, asymmetric linkers (5′-
GCGGTGACCCGGGAGATCTGAATTC-3′ and 5′-GAATTCAGATC-3′) are ligated to the
blunt ends using T4 DNA ligase, and then amplified by PCR with a primer complementary to
the linker.
For dual-channel microarray platforms, DNA derived from uncrosslinked cells, processed in
parallel to the crosslinked cells, is hybridized as the reference or input sample (Figure 1A). If
it is not possible to obtain uncrosslinked cells, which is often the case when cells are limited
or with tissues, crosslinks from a portion of the sample can be reversed and used as a reference.
Remove an aliquot from the cleared lysate following sonication. Reverse crosslinks by
incubating at 65° C overnight, and perform a phenol/chloroform extraction, ethanol
precipitation, and RNase A treatment.
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For tiling microarrays, raw data extraction is specific to the particular platform selected and
entails image acquisition and feature quantitation. Data can be expressed as a raw intensity for
single-channel platforms or as a log2 ratio for dual-channel platforms. For data preprocessing,
we typically normalize each dataset by calculating the z-score for each log2 ratio. The z-score
is calculated by subtracting the mean log2 ratio and dividing by the standard deviation, which
centers every dataset on the mean and standardizes the variance. In this way, every dataset has
a mean of 0 and standard deviation of 1. This methodology is only applicable to dual channel
platforms, although alternative strategies are available for single channel platforms [40,41].
Identification of regions enriched by FAIRE can be accomplished using most existing peak-
finding algorithms used for ChIP-chip experiments [42–45]. For microarray data we typically
use ChIPOTle [46], which uses a sliding window to identify statistically significant signals
that comprise a peak. The significance of each region is determined by reflecting the negative
portion of the data about zero, and then assuming a Gaussian distribution to estimate the null
distribution.
The three main user-adjustable parameters in ChIPOTle are window size, step size, and
threshold. Briefly we have found the following parameters to be optimal for analyzing FAIRE
data from oligonucleotide tiling microarrays. For microarrays with probes spaced every 38 bp
we use a window size of 300 bp. Whereas for probe spacing of every 60 to 100 bp we use a
500 bp window size. The larger window size is necessary to ensure a sufficient number of
probes are included in each window. We use a step size that is the average probe spacing, which
is measured as the start of one probe to the start of the next. We often try a range of thresholds
and look at how the overlap changes between replicates and genomic features.
High-throughput sequencing—Each of the high-throughput sequencing platforms
utilizes a different sample preparation procedure. We are most familiar with library preparation
of FAIRE DNA for the Illumina Genome Analyzer II (GAII) (Figure 1D). We use 100 to 200
ng of DNA for starting material. This procedure involves blunting the ends of the DNA
fragments (Epicentre #ER0720), adding an “A” overhang (Epicentre #KL06041K), and
ligating double-stranded adapters containing a T-overhang to the DNA fragments (Illumina
#1000521). Ligation products are then run on a 2% agarose gel, and a portion of the gel
corresponding to 125 bp– 275 bp is excised. It usually is not possible to see the DNA on the
gel at this point. PCR amplification is then carried out using PfuUltraII (Stratagene #600670)
and primers complimentary to the adapters (Illumina #1000537 and 1000538).
Raw data acquisition for the GAII entails image acquisition and base calling. Approximately
25 million mapped 36 bp reads are typically required for robust detection of FAIRE peaks in
a mammalian sample. Several algorithms are available for mapping the reads back to the
genome, each utilizing different computational and alignment strategies [47–49]. Typically we
use Maq [50], which incorporates information about read quality into the alignment. Since only
the first 36 bp from either end of each ~200 bp double-stranded DNA molecule is sequenced,
we computationally extend each aligned read to produce 200 bp extended reads. For
visualization, we count the number of extended reads overlapping every basepair in the
genome, and compute a density by dividing by the total number of bases contained within the
extended reads. These density estimates for each basepair can be loaded into genome browsers,
such as the UCSC genome browser (Figure 2) [51].
Several algorithms exist for identifying enriched regions [52,53] for high-throughput
sequencing data. Currently we use fseq [54], which calculates a density estimation for each
base pair by summing the set of Gaussian distribution representing the center of each extended
sequence read. Thresholds, based on the set of density estimates throughout the genome, can
then be used to identify enriched regions. In addition to identifying regions of open chromatin,
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we are also able to identify copy number variations by analyzing large-scale (100 kb to 1 Mbp)
changes in the data.
Concluding remarks
Several aspects of FAIRE make it a powerful genome-wide approach for detecting functional
in vivo regulatory elements in eukaryotes. It requires little treatment of cells prior to the addition
of formaldehyde and involves only a few reagents: formaldehyde, phenol, chloroform, and
ethanol. The successful application of FAIRE on a limited numbers of cells expands its utility
beyond what other DNA accessibility assays can accomplish. This provides an opportunity to
perform genome-wide assays of chromatin structure on tissue samples from patients, or to grow
cells in small-well plates to screen small molecules for chromatin effects. Additionally, since
FAIRE recovers the complete DNA fragments at regulatory elements it is possible to use this
material directly in functional assays, such as with reporter vectors.
Genome-wide maps of active regulatory elements will allow a better understanding of how the
availability of sequence-based regulatory elements are coordinated with the regulation of
factors that utilize them in a given cellular environment. The emerging set of consortium-based
datasets, such as those derived from the ENCODE project [55], will provide a foundation for
understanding the relationships among these factors, and be critical to constructing realistic
models of gene regulation in eukaryotic cells. The next major challenge will be to functionally
annotate the catalogue of regulatory elements discovered across a diverse set of cell types,
organisms, and disease states.
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Figure 1. FAIRE Procedure
(A) The FAIRE procedure described in the text is shown on the left, while preparation of the
reference or input sample is shown on the right. The DNA recovered from he aqueous phase
of each extraction can then be used to identify sites of open chromatin using qPCR, tiling
microarrays, or high-throughput sequencing applications. (B) For qPCR, a series of primers,
depicted as convergent arrows, are designed to span a genomic region of interest. Sites of open
chromatin are highlighted in blue, with qPCR results depicted above. Amplicons that span or
are near the boundaries of open chromatin often result in lower relative enrichment due to
shearing of DNA fragments, as shown by asterisks. (C) Microarrays. Typically we use high-
resolution microarrays that tile either regions of interest or the entire genome of an organism
with 50 to 70 bp oligonucleotides. (D) High-throughput sequencing technologies can be used
to map the DNA fragments back to the reference genome.
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Figure 2. FAIRE data
DNA isolated by FAIRE in human lymphoblastoid cells was mapped to the genome using both
the Illumina GAII (black) and NimbleGen tiling microarrays (red). A 60 kb region of
Chromosome 19 is displayed in the UCSC genome browser. For sequencing data, the number
of extended reads overlapping each base is plotted (see text). The FAIRE microarray data (red)
is plotted as z-scores (see text). Also shown is DNaseI hypersensitivity (blue) [56], and H3K4
mono-, di-, and tri-methylation from human CD4+ cells [57]. Each of these datasets are
represented as the density estimates from fseq. Black arrows represent the UCSC Known Genes
[58], with arrowheads indicating the direction of transcription. The FAIRE data colocalizes
with transcriptional start sites, DNaseI hypersensitive sites, and is adjacent to histone
modifications indicative of active 5′ ends of genes.
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Figure 3. Formaldehyde crosslinking efficiency as the basis for FAIRE
Crosslinking between histones and DNA (or between one histone and another) is likely to
dominate the chromatin crosslinking profile. (A) Here are a representative set of features from
eukaryotic chromatin, including nucleosomes (blue spheres), a DNA-binding protein (light
blue oval), and DNA (black line). Crosslinking with formaldehyde (red X) for most genomics
applications only captures a portion of the potential interactions. Given that histone-DNA
interactions constitute the majority of crosslinkable interactions in the genome, in a population
of cells (ten rows) all of these interactions are likely to be captured. Whereas only a small
proportion of the interactions between other DNA-binding proteins and DNA is actually
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captured by formaldehyde crosslinking. (B) The plot represents the expected FAIRE signal,
which is inversely correlated with the occurrence of crosslinkable protein-DNA interactions.
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